Cargando…

Role of Novel Dietary Supplement N-acetyl Cysteine in Treating Negative Symptoms in Schizophrenia: A 6-Month Follow-up Study

BACKGROUND: Abnormal metabolism of dopamine and glutamate in schizophrenia induces oxidative stress that is exacerbated by brain glutathione (GSH) deficiency. N-acetyl cysteine (NAC) increases brain GSH levels and is being used as an adjunctive agent in patients with schizophrenia. This open-label e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tharoor, Hema, Mara, Sindhu, Gopal, Subhashini
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009003/ https://www.ncbi.nlm.nih.gov/pubmed/29962570 http://dx.doi.org/10.4103/IJPSYM.IJPSYM_322_17

Ejemplares similares

Sexual dysfunctions in schizophrenia: Professionals and patients perspectives
por: Tharoor, Hema, et al.
Publicado: (2015)

Cognitive and negative symptoms in schizophrenia with L‐Carnosine adjuvant therapy – A randomized double‐blind placebo‐controlled study
por: Tharoor, Hema, et al.
Publicado: (2023)

Symptoms at Onset in First Episode Schizophrenia: Caregivers Perspectives
por: Tharoor, Hema, et al.
Publicado: (2015)

Exposure to the Dietary Supplement N-Acetyl-L-Cysteine during Pregnancy Reduces Cyclophosphamide Teratogenesis in ICR Mice
por: Miller, Brittany M., et al.
Publicado: (2018)

The Efficacy of N-Acetyl-Cysteine (NAC) Supplementation in FST Model for Screening Antidepressants
por: Memudu, Adejoke Elizabeth
Publicado: (2022)

The Antioxidant Role of Glutathione and N-Acetyl-Cysteine Supplements and Exercise-Induced Oxidative Stress
por: Kerksick, Chad, et al.
Publicado: (2005)

Tardive dyskinesia with low dose amisulpride
por: Tharoor, Hema, et al.
Publicado: (2013)

Birth Order and Psychopathology
por: Risal, Ajay, et al.
Publicado: (2012)

Evolution of Community Telepsychiatry in India Showcasing the SCARF Model
por: Tharoor, Hema, et al.
Publicado: (2020)

Treating Negative Symptoms in Schizophrenia: an Update
por: Remington, Gary, et al.
Publicado: (2016)

N-Acetyl-Cysteine: Modulating the Cysteine Redox Proteome in Neurodegenerative Diseases
por: Martinez-Banaclocha, Marcos
Publicado: (2022)

Improved oxidative status in major abdominal surgery patients after N-acetyl cystein supplementation
por: Kuyumcu, Aygun, et al.
Publicado: (2015)

NEGATIVE SYMPTOMS AND NEGATIVE SCHIZOPHRENIA
por: Chaturvedi, S.K., et al.
Publicado: (1984)

Acetyl-L-Carnitine as An Add-On Therapy for Negative and Cognitive Symptoms of Schizophrenia: A Randomized Control Trial
por: kulkarni, shalmali, et al.
Publicado: (2022)

Negative symptoms in schizophrenia
por: Mitra, Sayantanava, et al.
Publicado: (2016)

F230. COMPARISON OF PALIPERIDONE PALMITATE 3-MONTH AND PALIPERIDONE PALMITATE 1-MONTH FORMULATION FOR NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: A PHASE 3 NON-INFERIORITY STUDY
por: Mathews, Maju, et al.
Publicado: (2018)

Improvement of Negative Symptoms in Schizophrenia with Paliperidone Palmitate 1-Month and 3-Month Long-Acting Injectables: Results from a Phase 3 Non-Inferiority Study
por: Gopal, Srihari, et al.
Publicado: (2020)

N-Acetyl Cysteine as an Adjunct in the Treatment of Tuberculosis
por: Ejigu, Dawit A., et al.
Publicado: (2020)

F152. N-ACETYL-CYSTEINE SUPPLEMENTATION IMPROVES FUNCTIONAL CONNECTIVITY IN THE CINGULATE CORTEX IN EARLY PSYCHOSIS
por: Mullier, Emeline, et al.
Publicado: (2018)

N-Acetyl Cysteine Supplement Minimize Tau Expression and Neuronal Loss in Animal Model of Alzheimer’s Disease
por: Joy, Teresa, et al.
Publicado: (2018)

Time to onset and time to resolution of extrapyramidal symptoms in patients with exacerbated schizophrenia treated with 3-monthly vs once-monthly paliperidone palmitate
por: Mathews, Maju, et al.
Publicado: (2018)

N-acetyl-L-cysteine and cysteine increase intracellular calcium concentration in human neutrophils
por: Hasan, Md. Ashraful, et al.
Publicado: (2016)

N-Acetyl-l-Cysteine Supplement in Early Life or Adulthood Reduces Progression of Diabetes in Nonobese Diabetic Mice
por: Argaev Frenkel, Lital, et al.
Publicado: (2018)

Effects of N-acetyl-cysteine supplementation on sperm quality, chromatin integrity and level of oxidative stress in infertile men
por: Jannatifar, Rahil, et al.
Publicado: (2019)

NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND DEPRESSION
por: Chaturvedi, S.K., et al.
Publicado: (1985)

Efficacy of N-Acetyl Cysteine in Traumatic Brain Injury
por: Eakin, Katharine, et al.
Publicado: (2014)

A Review on Various Uses of N-Acetyl Cysteine
por: Mokhtari, Vida, et al.
Publicado: (2017)

N-acetyl Cysteine Use in the Treatment of Shock Liver
por: Parvataneni, Swetha, et al.
Publicado: (2020)

N-Acetyl-Cysteine Supplementation Improves Functional Connectivity Within the Cingulate Cortex in Early Psychosis: A Pilot Study
por: Mullier, Emeline, et al.
Publicado: (2019)

Effects of N-Acetyl-Cysteine Supplementation through Drinking Water on the Glutathione Redox Status during the Weaning Transition of Piglets
por: Degroote, Jeroen, et al.
Publicado: (2019)

The Impact of N-Acetyl Cysteine and Coenzyme Q10 Supplementation on Skeletal Muscle Antioxidants and Proteome in Fit Thoroughbred Horses
por: Henry, Marisa L., et al.
Publicado: (2021)

CATATONIC SYNDROME AS A COMPLICATION OF ENTERIC FEVER
por: Tharoor, Hema, et al.
Publicado: (2002)

Repurposing the antioxidant and anti-inflammatory agent N-acetyl cysteine for treating COVID-19
por: Finsterer, Josef, et al.
Publicado: (2022)

Glutathione Synthesis Is Diminished in Patients With Uncontrolled Diabetes and Restored by Dietary Supplementation With Cysteine and Glycine
por: Sekhar, Rajagopal V., et al.
Publicado: (2011)

Correction: Efficacy of N-Acetyl Cysteine in Traumatic Brain Injury
Publicado: (2014)

N-acetyl cysteine in aluminum phosphide poisoning: Myth or hope
por: Chaudhry, Dhruva, et al.
Publicado: (2014)

Suppression of cirrhosis-related renal injury by N-acetyl cysteine
por: Abdoli, Narges, et al.
Publicado: (2020)

S193. EFFICACY AND SAFETY OF TRANSCRANIAL DIRECT CURRENT STIMULATION FOR TREATING NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: THE FOLLOW-UP PHASE
por: Valiengo, Leandro, et al.
Publicado: (2020)

Tackling Negative Symptoms of Schizophrenia with Memantine
por: Paraschakis, Antonios
Publicado: (2014)

The Effects of Bupropion on Negative Symptoms in Schizophrenia
por: Yassini, Mojtaba, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bo4b87i3br674pte9p79fmhjfa